| Prev Close | 295.25 |
| Open | 297.29 |
| Day Low/High | 295.56 / 299.08 |
| 52 Wk Low/High | 208.34 / 305.45 |
| Volume | 1.79M |
| Avg Volume | 1.45M |
Thermo Fisher Scientific Inc. (TMO)
296.33
1.08
0.37
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 400.48M |
| Market Cap | 118.24B |
| EPS | 7.30 |
| P/E Ratio | 33.41 |
| Div & Yield | 0.76 (0.24%) |
Real Money Post-Industrial Average Leads Major Indexes So Far for Year
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
Feds Probe Tech, Mueller Speaks, Holy Guacamole and Now Hear NOW: Market Recon
Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms
Selected Earnings
United Parcel Service EPS: beat Revs: beat, +3.4% y/y Record profit across all segments Raised guidance AT&T EPS: in line Revs: in line, +15.3% y/y Subscriber losses Raised guidance for free cash flow General Dynamics EPS: beat Revs: beat, +4.0%...
Danaher Could Dip Near-Term, Providing a Buying Opportunity
DHR shares are up 35% in 2019.
Thermo Fisher Scientific Is Showing Us 3 Strong Charts
Here's how to play the stock right now.
Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin
Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.
Keep Your Eye on the Oncology Sector Among Biotech Stocks
The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.
Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon
I think we can all agree that there will be no increase made to the Fed Funds Rate today.
Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs
Let's check the charts and indicators.
How to Trade Microsoft Into Earnings: Market Recon
Add to longs near this key support level.
Jim Cramer: Valuations Now Have No Relation to Common Sense
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
How to Play a Possible Breakout in Starbucks: Market Recon
This options strategy on SBUX offers potential reward with little risk.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
Jim Cramer: Follow the Bouncing Equities
Markets start day with a bungee jump.
Uncertainty Is the New Market Normal -- And More Severe Tests Are Coming
There is likely more headline risk to our front than to our rear.
Big Pharma and the Sellers of Its Products Now Have a Problem
Who, out there in the health care sector, is safe?
Jim Cramer: The 3 Best Sectors That Lifted the Stock Market
It's hard to understand the magnitude of the change.
Cramer: Lessons From the Market and ICR
You can make a case to buy any of the stocks of the companies at ICR.
Six Off the Beaten Path Healthcare Stock Gems
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon
It looks like China is building again.
Cramer: Here Are the Ideal Stocks Now
All the great stocks have artificial intelligence and e-commerce in common.
Jim Cramer: Agilent Technology Has Been One of My Favorites
What's next for shares of Agilent Technology.
Cramer: Secondary Offerings Get Primary Attention
Thermo Fisher and McCormick deals show the true colors of stocks.
How to Get on Board Thermo Fisher Scientific
The stock could reach $200.
Cramer: There Are Powerful Themes in Several Bull Markets
It's a wonder to me how split this market really is.
Exxon, Thermo Fisher and 2 More Are Showing Red Flags
These big stocks are teetering on the edge of breakdown territory.
